Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Literature
1.
Gupta D, Chatterjee T, Sharma A, Ganguli P, Das S, Sharma S (2014) Rare case of acquired haemophilia and lupus anticoagulant. Indian J Hematol Blood Transfus 30:197–200CrossRefPubMed
2.
Ames PR, Graf M, Archer J, Scarpato N, Iannaccone L. Prolonged activated partial thromboplastin time: difficulties in discriminating coexistent factor VIII inhibitor and lupus anticoagulant. Clin Appl Thromb Hemost 2014. doi: 10.​1177/​1076029614541516​
3.
Triplett DA, Stocker KF, Unger GA, Barna LK (1993) The Textarin/Ecarin ratio: a confirmatory test for lupus anticoagulants. Thromb Haemost 70:925–931PubMed
4.
Moore GW, Smith MP, Savidge GF (2003) The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinized patients with lupus anticoagulants. Blood Coagul Fibrinolysis 14:307–312PubMed
5.
Brandt JT, Barna LK, Triplett DA (1995) Laboratory identification of lupus anticoagulants: results of the second international workshop for identification of lupus anticoagulants. On behalf of the subcommittee on lupus anticoagulants/antiphospholipid antibodies of the ISTH. Thromb Haemost 74:1597–1603PubMed
Metadata
Title
Co-existent Acquired Haemophilia and Lupus Anticoagulant. A Thorny Issue
Authors
Paul R. J. Ames
Daniel Montero
Jeremy Archer
Publication date
01-06-2016
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2016
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-015-0572-8

Other articles of this Special Issue 1/2016

Indian Journal of Hematology and Blood Transfusion 1/2016 Go to the issue

Case Report

CD5 Positive B Lymphoblastic Leukemia: Report of a Case with Review of Literature

Images

“Red Hand Syndrome” Due to Cytarabine in a Case of Mantle Cell Lymphoma

Correspondence

Cholestasis in a Patient of Multiple Myeloma: A Rare Occurrence of Bortezomib Induced Liver Injury

Case Report

All-Trans-Retinoic-Acid Unmasking Hypercalcemia of Hyperparathyroidism

Case Report

Systemic Mastocytosis with Associated Clonal Hematological Non-Mast Cell Lineage Disorder (MDS-RCMD): A Difficult Disease to Diagnose and Treat

Case Report

Congenital Dyserythropoietic Anemia Type 1: Report of One Patient and Analysis of Previously Reported Patients Treated with Interferon Alpha
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits